Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A New Model of Care for Patients with Central Nervous System Cancers: Final Results of a Pilot Study
Neuro-oncology
P2 - Poster Session 2 (8:00 AM-9:00 AM)
13-007

To determine the effect of an interdisciplinary approach to identify and address unmet need of patients (pts) with  central nervous system (CNS) cancers and their caregivers.


Pts with primary or metastatic CNS cancers have multiple physical, psychosocial, and spiritual needs. Neurological impairments can transform relationship with caregivers. These issues, prognosis, and end of care planning are difficult to address within a outpatient oncology clinic.

The Neurological Multidisciplinary Care Clinic (MdCC) at Memorial Sloan Kettering Cancer Center was a pilot study from 08/2017 to 06/2019 to foster a new model of care for complex pts with CNS cancers to identify and address their needs. Within a 3 hour single visit, a neurologist, nurse, physiatrist(RM), physical therapist, social worker(SW), case manager(CM), dietitian(RD), and chaplain(C)  rotated in to rooms to see patient/caregiver. Since 11/2017 participants completed validated surveys on unmet needs, financial strain, and home equipment prior to their visit and satisfaction surveys afterward. Descriptive statistics were used to analyze results.


Eighty-two pts with CNS cancers were seen: 40 were female, median age 59. Of these 82 pts, 66 had primary CNS cancers; predominantly high-grade glioma (79%). 56/82 pts were receiving cancer directed therapy. Over 60% had never seen a CM, RM, RD or C prior to MdCC. Seventy-eight pts (95%) received symptom management recommendations. Prognosis/coping with cancer was discussed with 75(91%) which increased signed health care proxy forms by 16% and DNR orders by 3% at the end of visit. New/updated physical therapy was ordered for 50 pts (61%); new equipment for 14(17%). Forty-nine pts completed a satisfaction survey; 96% were highly satisfied, and would recommend MdCC to others.


The presence of these providers allows for real time assessment of pts’/caregivers’ needs, their coping skills, discussing prognosis, assessing their support system and implementation of a safe pt's centered plan of care.  


Authors/Disclosures
Elena Pentsova, MD (Memorial Sloan-Kettering Cancer Center)
PRESENTER
The institution of Dr. Pentsova has received research support from YmAbs Therapeutics, Inc.
Kathryn S. Nevel, MD (Indiana University School of Medicine) Dr. Nevel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier Pharmaceuticals. Dr. Nevel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Nevel has received publishing royalties from a publication relating to health care. Dr. Nevel has received personal compensation in the range of $500-$4,999 for serving as a Interviewer with Continuum Audio.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Eli Diamond, MD (Memorial Sloan-Kettering Cancer Center) Dr. Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One Biopharmaceuticals. Dr. Diamond has received research support from Applebaum Foundation. Dr. Diamond has received research support from Frame Family Fund. Dr. Diamond has received research support from Joy Family West Foundation.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Alan C. Carver, MD (Memorial Sloan Kettering Cancer Center) No disclosure on file
No disclosure on file